Neumora Therapeutics (NMRA) Interest & Investment Income (2022 - 2026)
Neumora Therapeutics (NMRA) reported Interest & Investment Income of $935,000 for Q2 2026, down 58.4% from $2.25 million a year earlier and down 24.0% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Interest & Investment Income (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neumora Therapeutics' Interest & Investment Income came in at $5.19 million, down 61.9% year-over-year; for FY2025, it came in at $8.34 million, down 58.1% from FY2024.
- By year, Interest & Investment Income came in at $19.93 million in FY2024.
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income in data going back to Q3 2022.
- Year over year, Interest & Investment Income has now declined in each of the last four quarters, with an average decline of 47.2% over the last five quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.23 million (Q1 2026), $1.34 million (Q4 2025) and $1.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Neumora Therapeutics | 88.31 Mn | -529.65 Mn | - | 935,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 935,000.00 |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 4.21 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Dec 31, 2023 | 5.65 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 3.57 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 1.41 Mn |
API Access
Neumora Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();